The Spectrum of MR Imaging Patterns Suggestive of Pediatric Posterior Reversible Encephalopathy Syndrome in Children
Kerem Ozturk1, Alexander M McKinney2
1Department of Radiology, University of Minnesota Health, Minneapolis, MN.
Insights
Pediatric posterior reversible encephalopathy syndrome (pPRES) can occur in cerebral X-linked adrenoleukodystrophy (cALD). Recognizing cortical edema and leptomeningeal enhancement aids in diagnosing pPRES, while cALD white matter lesions persist.
Area of Science:
- Neuroimaging
- Pediatric Neurology
- Leukodystrophy
Background:
- Pediatric posterior reversible encephalopathy syndrome (pPRES) is a risk for children undergoing chemotherapy or immunosuppression.
- Cerebral X-linked adrenoleukodystrophy (cALD) is a rare genetic disorder affecting the white matter of the brain.
- pPRES in cALD patients is not well-described, despite hematopoietic stem cell transplantation improving outcomes.
Purpose of the Study:
- To describe the distinct lesion patterns, distribution, and evolution of neuroimaging findings in pPRES within a pediatric cALD cohort.
- To analyze the association between imaging features and clinical outcomes in cALD patients with pPRES.
Main Methods:
- Retrospective review of brain MRIs from pediatric cALD patients (1995-2020).
- Analysis of clinical features, conventional MRI, and diffusion-weighted imaging.
- Examination of gray matter and white matter changes suggestive of concurrent PRES-cALD.
Main Results:
- Eight pediatric cALD patients presented with symptoms of PRES (seizures, headache, altered mental status).
- MRI revealed concurrent cortical-subcortical vasogenic edema (pPRES) overlying periventricular white matter involvement (cALD).
- Lesions were reversible in 7/8 patients, with partial reversibility in one.
Conclusions:
- pPRES is a recognized complication in pediatric cALD.
- Cortical edema and leptomeningeal enhancement can expedite pPRES diagnosis in cALD.
- Periventricular white matter lesions characteristic of cALD persist after pPRES resolution.
Background And Purpose:
Children receiving chemotherapy, or immunosuppression have an increased risk for pediatric posterior reversible encephalopathy syndrome (pPRES); pPRES is scantly described in cerebral X-linked adrenoleukodystrophy (cALD) patients, for which hematopoietic stem cell transplantation improves outcomes. This study aimed to describe distinctive lesion patterns, distribution, and evolution of neuroimaging findings in PRES in a single-center pediatric cohort of cALD.
Methods:
We retrospectively identified all clinically acquired brain MRIs of children with cALD at a tertiary care university hospital between 1995 and 2020. We reviewed clinical features, conventional MRI, and diffusion-weighted imaging findings of patients with gray matter and white matter (WM) changes suggestive of concurrent PRES-cALD. Associations between the distinctive anatomic features, distribution, and abnormal signal intensity on MRI were examined with regard to the etiology and clinical outcome.
Results:
Our search revealed a series of eight pediatric cALD patients presenting with seizures, headache, or altered mental status with MRI findings suggestive of both PRES and cALD simultaneously. In each, the cortical-subcortical vasogenic edema on fluid-attenuated inversion recovery was consistent with pPRES, overlying the periventricular WM (PVWM) involvement typical of cALD. Of these 8 patients, the cortical-subcortical lesions on FLAIR were completely reversible on follow-up MRI in 7, but only partially reversible in 1.
Conclusions:
It is crucial to recognize that pPRES can occur in cALD, notably, the cortical edema and leptomeningeal enhancement can accelerate the diagnosis of superimposed pPRES, while the PVWM lesions of cALD remain following the resolution of pPRES.
More Related Videos
05:52Early Pathological and Magnetic Resonance Detection of Cerebral Injury Using a Rat Model of Neonatal Hypoxic Ischemic Encephalopathy
Published on: October 28, 2022
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Cerebral Edema ll: Pathophysiology
